Yeah: 10:30 AM EDT, 03/24/2017 (MT Newswires) -- Regulus Therapeutics (RGLS) shares jumped 15% higher Friday morning after the company's chairman, Papadopoulos Stelios, disclosed in a filing with U.S. regulators that he has acquired 0.5 million shares of common stock of the company.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.